Rheumatology

Psoriatic arthritis treatment often relies on a trial-and-error approach, leading to delays in effective therapy and increased healthcare costs . A new clinical prediction model may help personalize treatment selection for methotrexate, tofacitinib, and eta...

For patients with psoriatic arthritis , treatment selection often feels like a shot in the dark; this model aims to refine that process. It offers a practical tool to predict individual responses to methotrexate, tofacitinib, or etanercept, potentially stre...

A new clinical prediction model aims to optimize treatment selection for Psoriatic Arthritis patients receiving methotrexate, tofacitinib, or etanercept. This development could influence treatment guidelines and payer decisions by improving the precision of...

The diagnostic odyssey for children with rare rheumatic diseases can be shortened by recognizing key clinical clues early. Improved diagnostic strategies and referral pathways are essential to reduce patient suffering and improve outcomes.

Rare disease research offers an untapped reservoir of insights, potentially reshaping how we understand and treat pediatric rheumatology . Integrating multi-omics approaches could redefine diagnostic precision and therapeutic strategies for complex diseases.

Families bear a disproportionate burden from rare pediatric diseases. Strategic investment in research offers both humanitarian and economic returns.